Table 2.
Patient total costs, length of stay, and treatments received while terminally hospitalized for advanced liver disease from 2009 to 2013
| Variable | Total Sample, N (%) or Mean, (SD) | Receiving Palliative Care, N (%) or Mean (SD) | Not Receiving Palliative Care, N (%) or Mean (SD) |
|---|---|---|---|
| Total Cost* | $49,167 (1,169) | $45,710 (1,588) | $50,622 (1,379) |
| 2009 | $47,766 (2,838) | $45,864 (4,618) | $48,176 (2,954) |
| 2010 | $48,089 (2,429) | $48,547 (3,880) | $47,925 (2,476) |
| 2011 | $47,847 (3,256) | $43,365 (3,336) | $49,979 (4,128) |
| 2012 | $50,009 (2,346) | $43,751 (2,731) | $53,210 (2,975) |
| 2013 | $51,435 (2,335) | $47,574 (2,832) | $53,560 (2,710) |
| Length of Stay* | 14.0 (0.21) | 12.6 (0.29) | 14.6 (0.26) |
| Treatments Received | |||
| Mechanical Ventilation* | 33,246 (55.7%) | 8,443 (48.6%) | 24,798 (58.6%) |
| Hemodialysis* | 9,251 (15.5%) | 2,437 (14.0%) | 6,820 (16.1%) |
| Blood Transfusion* | 26,019 (43.6%) | 7,065 (40.7%) | 18,963 (44.8%) |
| Parenteral Nutrition | 7,877 (13.2%) | 2,378 (13.7%) | 5,502 (13.0%) |
| Cardiopulmonary Resuscitation* | 3,689 (6.2%) | 469 (2.7%) | 3,217 (7.6%) |
| Endoscopy* | 14,623 (24.5%) | 3,777 (21.7%) | 10,836 (25.6%) |
| Paracentesis* | 23,910 (40.1%) | 7,429 (42.8%) | 16,466 (38.9%) |
| Transjugular Intrahepatic Portosystemic Shunt | 1,890 (3.2%) | 472 (2.7%) | 1,418 (3.4%) |
| Blakemore Tube | 255 (0.4%) | 74 (0.4%) | 181 (0.4%) |
| Radiofrequency Ablation | 69 (0.1%) | 15 (0.1%) | 54 (0.1%) |
| Trans-arterial Chemoembolization | 318 (0.5%) | 93 (0.5%) | 225 (0.5) |
| Liver Transplant* | 444 (0.7%) | 55 (0.3%) | 389 (0.9%) |
*
denotes result is significant for α < 0.05 for bivariate analysis.